Bellevue Group’s Halozyme HALO Stock Holding History

Bellevue Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	4,348 +491	+13%	+$33.5K	0.01%	119
2026 Q1	$249K	Buy	+3,857	New	+$272K	0.01%	129
2023 Q2	–	Sell	-742,400	Closed	-$28.4M	–	160
2023 Q1	$28.4M	Sell	742,400 -70,300	-9%	-$3.3M	0.41%	64
2022 Q4	$46.2M	Sell	812,700 -117,800	-13%	-$6.03M	0.61%	54
2022 Q3	$36.8M	Sell	930,500 -40,800	-4%	-$1.8M	0.53%	55
2022 Q2	$42.7M	Sell	971,300 -52,900	-5%	-$2.29M	0.6%	52
2022 Q1	$40.8M	Sell	1,024,200 -43,300	-4%	-$1.54M	0.47%	66
2021 Q4	$42.9M	Buy	1,067,500 +146,000	+16%	+$5.45M	0.44%	69
2021 Q3	$37.5M	Sell	921,500 -1,302,966	-59%	-$54.5M	0.38%	81
2021 Q2	$101M	Sell	2,224,466 -787,500	-26%	-$34.9M	0.99%	28
2021 Q1	$126M	Sell	3,011,966 -1,033,034	-26%	-$47.2M	1.33%	21
2020 Q4	$173M	Sell	4,045,000 -1,424,131	-26%	-$51.2M	1.98%	12
2020 Q3	$144M	Sell	5,469,131 -1,261,421	-19%	-$35.1M	1.99%	12
2020 Q2	$180M	Sell	6,730,552 -933,404	-12%	-$21.1M	2.55%	10
2020 Q1	$138M	Sell	7,663,956 -372,900	-5%	-$7.08M	2.67%	8
2019 Q4	$142M	Buy	8,036,856 +22,500	+0.3%	+$390K	2.26%	10
2019 Q3	$124M	Sell	8,014,356 -233,504	-3%	-$3.85M	2.31%	10
2019 Q2	$142M	Buy	+8,247,860	New	+$133M	2.42%	11
2018 Q2	–	Sell	-75,800	Closed	-$1.49M	–	142
2018 Q1	$1.49M	Sell	75,800 -1,200	-2%	-$23.2K	0.15%	97
2017 Q4	$1.56M	Sell	77,000 -10,600	-12%	-$195K	0.16%	92
2017 Q3	$1.52M	Sell	87,600 -131,400	-60%	-$1.78M	0.16%	94
2017 Q2	$2.81M	Sell	219,000 -51,000	-19%	-$681K	0.33%	67
2017 Q1	$3.5M	Sell	270,000 -48,000	-15%	-$607K	0.47%	61
2016 Q4	$3.14M	Hold	318,000	–	–	0.64%	45
2016 Q3	$3.84M	Hold	318,000	–	–	0.69%	47
2016 Q2	$2.74M	Hold	318,000	–	–	0.52%	59
2016 Q1	$3.01M	Buy	+318,000	New	+$2.99M	0.55%	60

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Bellevue Group's HALO Position: Q2 2026 in Review

Bellevue Group increased its Halozyme (HALO) stake by 13% in Q2 2026, buying an estimated $33.5K and bringing the position to 4,348 shares worth $340K. The position accounts for 0.01% of the portfolio, ranked #119.

Bellevue Group first reported a position in HALO in Q1 2016 and has held it in 27 quarters since. The position peaked at $180M in Q2 2020. 605 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Bellevue Group held 4,348 shares of Halozyme worth $340K as of Q2 2026.
Bellevue Group bought 491 Halozyme shares in Q2 2026, an estimated $33.5K.
Halozyme made up 0.01% of Bellevue Group's portfolio in Q2 2026, its #119 holding.
Bellevue Group first reported a position in Halozyme in Q1 2016 and has held it in 27 quarters since.
Bellevue Group's Halozyme position peaked at $180M in Q2 2020.
605 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bellevue Group's 13F filing for Q2 2026, filed 14 Aug 2026.